Financial Year |
March 31 2023 |
Monetary Funds |
285,930,948.01 |
Held-for-trading Financial Assets |
808,872,259.07 |
Notes Receivable |
82,679,780.09 |
Accounts Receivable |
268,006,336.75 |
Advances to Suppliers |
72,882,654.32 |
Other Receivables |
10,204,400.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
172,451,821.21 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
494,431,620.49 |
Total Current Assets |
2,195,459,820.75 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
62,035,933.07 |
Investment Properties |
-- |
Fixed Assetes |
205,257,548.17 |
Under-construction Projects |
43,481,513.99 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
33,618,839.97 |
R&D expenses |
-- |
Goodwill |
60,265.73 |
Long-Term Deferred and Prepaid Expenses |
205,856.86 |
Deferred Income Tax Assets |
13,533,107.35 |
Other Non-Current Assets |
34,703,383.48 |
Sub-Total of Non-Current Assets |
453,701,046.87 |
Total Assets |
2,649,160,867.62 |
Short-Term Loans |
339,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
10,205,426.06 |
Accounts Payable |
146,237,866.36 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
3,056,272.37 |
Taxes Payable |
32,339,405.64 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,095,378.38 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
4,179,222.07 |
Other Current Liabilities |
167,886.21 |
Sub-Total of Current Liabilities |
542,602,648.29 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
15,201,960.29 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
68,495,062.79 |
Total Liabilities |
611,097,711.08 |
Paid-In Capital(Or Share Stock) |
791,528,907.00 |
Capital Surplus |
150,935,658.97 |
Surplus Reserve |
98,597,764.28 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
880,074,074.37 |
Minority Stockholder's Interest |
118,407,842.71 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,919,655,313.83 |
Owner's Equity(Stockholder's Equity) |
2,038,063,156.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,649,160,867.62 |